SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Steve168 who wrote (14915)12/24/2004 12:11:19 AM
From: John Metcalf  Respond to of 52153
 
There is a thread for biotechs below cash. No activity since last July.

Subject 52724



To: Steve168 who wrote (14915)12/24/2004 10:21:36 AM
From: fred hayes  Read Replies (1) | Respond to of 52153
 
Praecis: looks undervalued on its face, but I gave up on it. If you think their drug for prostate cancer (abarelix sp?)will sell, then PRCS is a bargain. So far, the docs don't seem to want it. It is a hassle to deal with, sales have been in the toilet, and its difficult to keep tabs on progress. I sold my position and don't follow it anymore. I don't think others on this board follow it either, it has not been discussed for a long time...

fred hayes